2025年英国风湿病学会抗中性粒细胞胞质抗体相关性血管炎管理推荐
英国风湿病学会抗中性粒细胞胞质抗体相关性血管炎工作组基于已发表指南、系统文献综述及英国专科血管炎中心与患者代表意见,更新2014年指南,形成涵盖GPA与MPA治疗、声门下狭窄及耳鼻喉表现管理、EGPA管理、服务规范、患者教育与支持五大领域的26条推荐,并附一致性强度评分及研究与审计建议。
要点
- 推荐涵盖GPA与MPA治疗、声门下狭窄及耳鼻喉表现、EGPA管理、服务规范、患者教育与支持五大领域,共26条。
- 每条推荐附一致性强度评分,基于已发表指南、系统文献综述及英国专科血管炎中心与患者代表意见制定。
- 推荐更新自2014年BSR与BHPR指南,并提供研究与审计建议以支持公平获取照护和改善健康结局。
核心结论
- 这些推荐基于当前证据与专家意见,提供了AAV照护的更新,并附研究与审计建议以支持公平获取照护和改善健康结局。
研究设计与样本
- BSR AAV工作组审阅已发表指南、开展系统文献综述,并利用英国专科血管炎中心专家意见与患者代表意见,制定26条推荐及相应一致性强度评分。
主要发现
- 26条推荐涵盖五个关键领域:GPA与MPA的治疗;声门下狭窄及AAV耳鼻喉表现的管理;EGPA的管理与治疗;服务规范;患者教育与支持。
- 推荐更新自2014年BSR与BHPR已发表指南。
- 此外提供了研究与审计建议以支持公平获取照护和改善健康结局。
关键数值与推荐
- 26条推荐均附相应一致性强度评分,原文未报告具体评分数值。
临床怎么用
- 原文未据此给出具体临床推荐条款。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ANCA-associated vasculitis (AAV) is comprised of three specific conditions: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). Since the publication of the last British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) guideline for the management of adults with AAV in 2014, a plethora of randomized controlled trials, additional research and recommendations have provided novel insights into how the management of AAV can be optimized, thus improving patient quality of life. The BSR AAV Working Group (WG) reviewed published guidelines, undertook a systematic literature review and utilized expertise from specialist vasculitis centres across the UK and patient representatives to formulate a list of 26 recommendations with corresponding strength of agreement (SOA) scores. Recommendations were updated from the published 2014 BSR and BHPR guideline. The 26 recommendations encompassed five key domains: 1. Treatment for GPA and MPA; 2. Management of subglottic stenosis and ear, nose and throat (ENT) manifestations of AAV; 3. Management and treatment for EGPA; 4. Service specifications; 5. Patient education and support. These recommendations provide an update on care delivery of AAV based on current evidence and specialist opinion. In addition, we have provided research and audit recommendations to support equitable access to care and improve health outcomes. The lay summary that accompanies this abstract can be found in Supplementary Data S1, available at Rheumatology online.
引用
- Biddle K, Jade J, Wilson-Morkeh H, et al. The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis. Rheumatology (Oxford). 2025. PMID: 40499922. doi:10.1093/rheumatology/keaf240
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。